The shares of cannabis companies are attracting investors’ attention again. While everyone is waiting for marijuana legalization in the USA, let us consider the main players of the sectors as investment options.
Tilray stocks dropped after growth, and even a strong quarterly report was no remedy. Experts say that the only chance for success is the company’s merger with Aphria, which was confirmed by the decline in its quotations right before and after the report.
This week, the stocks of cannabis companies first sky-rocketed, then slid down. Analysts name several factors that influenced the market of medical and recreational cannabis, the actions of WallStreetBets subscribers among them.